Progeria: A Genetic Disorder of Premature Aging

Progeria: A Genetic Disorder of Premature Aging
Slide Note
Embed
Share

Progeria, also known as Hutchinson-Gilford progeria syndrome (HGPS) or Werner syndrome, is a rare genetic disorder characterized by premature aging. It affects physical development more than intellectual development and comes with symptoms such as slow growth, alopecia, joint abnormalities, and cardiovascular disease. While there is no known cure, treatments aim to manage the symptoms, with promising results seen with Farnesyltransferase Inhibitors. The life expectancy of individuals with progeria is tragically short, with a 100% fatality rate due to complications like heart attacks or strokes.

  • Progeria
  • Genetic Disorder
  • Rare Disease
  • Premature Aging
  • HGPS

Uploaded on Feb 19, 2025 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. Progeria The disease of accelerated aging By: A.Campbell 11.14.13

  2. Definition: A genetic disorder that results in premature aging Hutchinson-Gilford progeria syndrome (HGPS) Werner Syndrome

  3. Background Information Prevalence: Rare 130+ cases since 1886 Physical Development vs. Intellectual Development Autosomal Dominant

  4. Symptoms: What and When

  5. What are the symptoms? Slow growth/ weight gain Alopecia Joint abnormalities Cardiovascular disease Loss of subcutaneous fat

  6. When do they start? After Infancy Children look normal at birth/early infancy

  7. Physical features Prominent eyes Thin, beaked nose Thin Lips Small chin

  8. Treatments No known cure Treat the symptoms Promising results with Farnesyltransferase Inhibitors Treats the cause of progeria

  9. Life Expectancy 100% Fatality rate Die of symptoms Most often heart attack or stroke Live for about ~13 years

  10. GENETICS: LMNA Gene

  11. LMNA Gene Linked to progeria in 2003 Discovered by NHGRI team led by Francis Collins

  12. LMNA Gene Produces Lamin A/C Lamin A is a nuclear membrane protein Maintains structural integrity of nucleus Located 1q22

  13. Mutated LMNA Gene Single point mutation C1824T Truncates Lamin A = progerin

  14. Progerin Lamin A requires posttranslation modification Farnesyl group is removed Progerin lacks the cleavage site needed to removed the Farnesyl group

  15. Progerin Farnesylation: facilitates membrane association What does this mean for progerin?? What does this mean for the nucleus?? Collins Lab study: supports theory

  16. "Connecting this rare disease and normal aging is bearing fruit in an important way...valuable biological insights are gained by studying rare disorders such as Progeria. Our sense from the start was that Progeria had a lot to teach us about the normal aging process." - Dr. Francis Collins, Director of the National Institutes of Health Current Research

  17. Role of progerinin normal aging NHGRI linked telomere length to progerin production Cells w/ high telomerase levels had little progerin production Studied normal cells- ages 10-92YO

  18. Breakthrough Treatment FTIs Show reversal of HGPS symptoms

  19. Have we found a cure? Lonafarnib- FTI Weight gain- increased bone density + lean body mass Aortic stiffness decreased

  20. References http://www.nih.gov/news/health/jun2011/nhgri-13.htm http://www.genome.gov/27534095 http://ghr.nlm.nih.gov/gene/LMNA http://www.progeriaresearch.org/first-ever-progeria-treatment.html Gordon et. al., Clinical Trial of a Farnesyltransferase Inhibitor in Children with Hutchinson-Gilford Progeria Syndrome, PNAS, October 9, 2012 vol. 109 no. 41 16666-16671 http://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=59 http://www.ncbi.nlm.nih.gov/pubmed/11842430 http://www.pnas.org/content/109/41/16666.full http://ghr.nlm.nih.gov/condition/hutchinson-gilford-progeria- syndrome http://www.genome.gov/11007255

More Related Content